Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: A comparison

Drug and Alcohol Dependence

Volumn 52, Issue 1, 1998, Pages 79-84

  Charnaud, Ben ^a   Griffiths, Vanessa ^b  

^a Trengweath ^*  (United Kingdom)

^b St Lawrences Hospital Bodmin   (United Kingdom)

Author keywords

Amphetamine misuse; Intravenous drug misuse; Opiate misuse; Substitute prescribing

Indexed keywords

DEXAMPHETAMINE; METHADONE; OPIATE;

ADOLESCENT; ADULT; ARTICLE; DRUG DEPENDENCE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 0032169083     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00052-0     Document Type: Article

References (17)

1. Connell, P.H., 1958. Amphetamine Psychosis. Maudsley Monograph No. 5. Oxford University Press, Oxford.
2. Darke, S., Cohen, J., Ross, J., Hando, J., Hall, W., 1994. Transitions between routes of administration of regular amphetamine users. Addiction 89 (9), 1077-1083.
3. Department of Health, 1996. The Task Force to Review Services for Drugs Misusers: Report of an Independent Review of Drugs Treatment Services in England. Department of Health, London.
4. Fleming, P.M., Roberts, D., 1994. Is the prescription of amphetamine justified as a harm reduction measure. J. R. Soc. Health 114 (3), 127-131.
5. Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, J., Strang, J., 1995. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90 (5), 607-614.
6. Hall, W., Hando, J., Darke, S., Ross, J., 1996. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 91 (1), 81-87.
7. Hando, J., Topp, L., Hall, W., 1997. Amphetamine related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug Alcohol Depend. 46, 105-113.
8. Hawkes, D., Mitcheson, M., Ogborne, A., Edwards, G., 1969. Abuse of methylamphetamine. Br. Med. J. 21 June (2), 715-721.
9. Harris, N.V., Thiede, H., McGough, J.P., Gordon, D., 1993. Risk factors for HIV infection among injection drug users. J. Acquired Immune Defic. Syndr. 6, 1275-1282.
10. Keene, J., Stimson, G.V., Jones, S., Parry-Langdon, N., 1993. Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales. Addiction 88 (8), 1063-1070.
11. Klee, H., 1992. A new target for behavioural research - amphetamine misuse. Br. J. Addiction 87 (4), 439-446.
12. Klee, H., 1993. HIV risks for women drug injectors: heroin and amphetamine users compared. Addiction 88 (8), 1055-1062.
13. Mattick, R.P., Darke, S., 1995. Drug replacement treatments: is amphetamine substitution a horse of a different colour? Drug Alcohol Rev. 14, 389-394.
14. Pates, R., 1994. Speed on prescription. Druglink May/June, 16-17.
15. Wallen, J., Berman, K., 1992. Possible indicators of childhood sexual abuse for individuals in substance abuse treatment. J. Child Sexual Abuse 1 (13), 63-74.
16. Weinrieb, R.M., O'Brien, C.P., 1993. Persistent cognitive deficits attributed to substance abuse. Neurol. Clin. 11 (3), 663-691.
17. Willoughby, S., Hager, K., Miller, J., Turner, S., 1989. Prescribing for amphetamine users in Exeter: interim report. Report of a SCODA Members Conference, 5 October 1989.